Autologous adipose-derived mesenchymal stem cells (Mayo Clinic)

N/A

Report date: 2026/04/07 20:00:20

Base Information

Drug NameAutologous adipose-derived mesenchymal stem cells (Mayo Clinic)
Drug Alias Name脂肪源间充质干细胞
ClassificationCell and gene therapy > Cell therapy > Donor > AutologousCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapyCell and gene therapy > Cell therapy > Source of cells > Adipose-derived
Mechanisms of ActionStem cell replacements
TargetsNot applicable
Therapy Area/IndicationsDiabetes Mellitus, Type 2Diabetes Mellitus, Type 1Kidney Failure, Chronic +[16] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesMayo Clinic
China Registration ClassN/A

Develop Information

Active CompaniesMayo Clinic
Inactive CompaniesN/A
Active IndicationsKidney Failure, ChronicParalysisSpinal Cord Injuries +[7] 
Inactive IndicationsDiabetes Mellitus, Type 2Diabetes Mellitus, Type 1Renal Insufficiency, Chronic +[9] 

Other Information

ATC CodeN/A
Related LinksN/A